Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Ocular Therapeutix (OCUL)
NASDAQ:OCUL
Ocular Therapeutix (OCUL) Stock Price & Analysis
950 Followers
OCUL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.57 - $7.32
Previous Close$6.92
Volume267.37K
Average Volume (3M)978.90K
Market Cap
$542.29M
Enterprise Value$522.06M
Total Cash (Recent Filing)$79.03M
Total Debt (Recent Filing)$64.61M
Price to Earnings (P/E)-6.0
Beta0.83
Next Earnings
Aug 07, 2023EPS Estimate
-$0.28Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.16
Shares Outstanding77,524,666
10 Day Avg. Volume1,084,340
30 Day Avg. Volume978,905
Standard Deviation0.22
R-Squared0.10
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)105.32
Price to Sales (P/S)40.11
Price to Cash Flow (P/CF)-6.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue10.10
Enterprise Value/Gross Profit11.12
Enterprise Value/Ebitda-6.58
Forecast
1Y Price Target
$13.00Price Target Upside85.85% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Ocular Therapeutix News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OCUL FAQ
What was Ocular Therapeutix’s price range in the past 12 months?
Ocular Therapeutix lowest stock price was $2.57 and its highest was $7.32 in the past 12 months.
What is Ocular Therapeutix’s market cap?
Currently, no data Available
When is Ocular Therapeutix’s upcoming earnings report date?
Ocular Therapeutix’s upcoming earnings report date is Aug 07, 2023 which is in 63 days.
How were Ocular Therapeutix’s earnings last quarter?
Ocular Therapeutix released its earnings results on May 08, 2023. The company reported -$0.39 earnings per share for the quarter, missing the consensus estimate of -$0.263 by -$0.127.
Is Ocular Therapeutix overvalued?
According to Wall Street analysts Ocular Therapeutix’s price is currently Undervalued.
Does Ocular Therapeutix pay dividends?
Ocular Therapeutix does not currently pay dividends.
What is Ocular Therapeutix’s EPS estimate?
Ocular Therapeutix’s EPS estimate is -$0.28.
How many shares outstanding does Ocular Therapeutix have?
Ocular Therapeutix has 77,524,666 shares outstanding.
What happened to Ocular Therapeutix’s price movement after its last earnings report?
Ocular Therapeutix reported an EPS of -$0.39 in its last earnings report, missing expectations of -$0.263. Following the earnings report the stock price went up 2.344%.
Which hedge fund is a major shareholder of Ocular Therapeutix?
Among the largest hedge funds holding Ocular Therapeutix’s share is Graham Capital Management, L.P.. It holds Ocular Therapeutix’s shares valued at 409K.
---
Ocular Therapeutix Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$13.00 (85.85% Upside)
$13.00 (85.85% Upside)
Blogger Sentiment
Bullish
OCUL Sentiment 75%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 77.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.5%
Last 30 Days ▲ 5.7%
Last 30 Days ▲ 5.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
117.61%
12-Months-Change
Fundamentals
Return on Equity
-198.45%
Trailing 12-Months
Asset Growth
-31.47%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Ocular Therapeutix
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
---
Top 5 ETFs holding OCUL
iShares Core S&P Total U.S. Stock Market ETF
$521.59K
iShares NASDAQ US Biotechnology UCITS ETF
$230.47K
iShares Russell 3000 ETF
$172.88K
Dimensional U.S. Equity ETF
$71.33K
Invesco Nasdaq Biotechnology ETF
$10.14K
Up to five ETFs with an Outperform Smart Score that hold OCUL. The ETFs are listed according to market value of OCUL within the ETF
---
---